Clinical Trial

DOMPE -MT Neurotrophic Keratitis

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated September 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment with Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic Keratitis
Trial Details
NCT Number NCT06947850
Lead Sponsor Toyos Clinic
Conditions Dry Eye, Neurotrophic Keratitis
Enrollment 10 participants
Start Date 2023-01-21
Primary Completion 2025-09-25 (estimated)
Study Completion 2025-09-25 (estimated)
Updated on ClinicalTrials.gov 2025-04-27